RPL9P31

Across TCGA pan-cancer cohorts, RPL9P31 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPL9P31’s most consistent transcriptional readouts.

The strongest signal is observed in rectum adenocarcinoma (READ), where RPL9P31 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL9P31 is over-expressed in tumor, although a few such as READ and HNSC show the opposite, repressed pattern.

READ, LIHC, and HNSC are the cancer types where RPL9P31 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL9P31 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
READ	All	III,IV	−0.145	.028	2	view →
LIHC	All	III,IV	+0.052	.041	2	view →
HNSC	Female	II,III,IV	−0.050	.021	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPL9P31–READ

Open the READ breakdown →